Comparative outcomes for patients who do and do not undergo percutaneous coronary intervention for stable coronary artery disease in new york

Circulation

Volumn 125, Issue 15, 2012, Pages 1870-1879

  Hannan, Edward L ^a   Samadashvili, Zaza ^a   Cozzens, Kimberly ^a   Walford, Gary ^b   Jacobs, Alice K ^c   Holmes, David R ^d   Stamato, Nicholas J ^e   Gold, Jeffrey P ^f   Sharma, Samin ^g   Venditti, Ferdinand J ^h   Powell, Tia ⁱ   King, Spencer B ^j  

^a UNIVERSITY AT ALBANY   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c BOSTON MEDICAL CENTER   (United States)

^d MAYO CLINIC   (United States)

^e United Health Services   (United States)

^f MEDICAL COLLEGE OF OHIO   (United States)

^g MOUNT SINAI MEDICAL CENTER   (United States)

^h ALBANY MEDICAL CENTER   (United States)

ⁱ MONTEFIORE MEDICAL CENTER   (United States)

^j St Joseph's Health System   (United States)

more..

Author keywords

comparative effectiveness research; coronary angioplasty; coronary artery disease; medicine

Indexed keywords

AGED; ARTICLE; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; FEMALE; FOLLOW UP; HEART CATHETERIZATION; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; TREATMENT OUTCOME; UNITED STATES;

AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON, CORONARY; CORONARY ARTERY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; PROPENSITY SCORE; TREATMENT OUTCOME;

EID: 84863393773     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.111.071811     Document Type: Article

References (26)

1. Boden WE, O'Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, Knudtson M, Dada M, Casperson P, Harris CL, Chaitman BR, Shaw L, Gosselin G, Nawaz S, Title LM, Gau G, Blaustein AS, Booth DC, Bates ER, Spertus JA, Berman DS, Mancini J, Weintraub WS. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356:1503-1516.
2. Weintraub WS, Spertus JA, Kolmn P, Maron DJ, Zhang Z, Jurkovitz C, Zhang W, Hartigan PM, Lewis C, Veledar E, Bowen J, Dunbar SB, Daeton C, Kaufman S, O'Rourke RA, Goeree R, Barnett PG, Teo KK, Boden WE. Effect of PCI on quality of life inpatients with stable coronary disease. N Engl J Med. 2008;359:677-687.
3. Maron DJ, Boden WE, Weintraub WS, Calfas KJ, O'Rourke RA. Is optimal medical therapy as used in the COURAGE trial feasible for widespread use? Curr Treat Options Cardiovasc Med. 2011;13: 16-25.
4. Maron DJ, Boden WE, O'Rourke RA, Hartigan PM, Kalfas KJ, Mancini J, Spertus JA, Dada M, Kostuk WJ, Knudtson M, Harris CL, Sedlis SP, Zoble RG, Title LM, Gosselin G, Nawaz S, Gau GT, Blaustein AS, Bates ER, Shaw LJ. Intensive multifactoral intervention for stable coronary artery disease: optimal medical therapy in the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug evaluation) trial. J Am Coll Cardiol. 2010;55:1348-1358.
5. O'Gara PT. The COURAGE (Clinical Outcomes Utilizing Revascular-ization and Aggressive Drug Evaluation) trial: can we deliver on its promise? J Am Coll Cardiol. 2010;56:1359-1361.
6. Kereiakes DJ, Teitstein PS, Sarembock IJ, Holmes DR Jr, Krucoff MW, O'Neill WW, Waksman R, Williams DO, Popma JJ, Buchbinder M, Mehran R, Meredith IT, Moses JW, Stone GW. The truth and consequences of the COURAGE trial. J Am Coll Cardiol. 2007;50: 1598-1603.
7. Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70:41-55.
8. Rosenbaum PR. Optimal matching for observational studies. JASA. 1989; 84:41-55.
9. Ming K, Rosenbaum PR. A note on optimal matching with variable controls using the assignment algorithm. J Comput Graph Stat. 2001;10: 455-463.
10. Gu XS, Rosenbaum PR. Comparison of multivariate matching methods, structures, differences, and algorithms. J Comput Graph Stat. 1993;2: 405-420.
11. Austin PC, Grootendorst P, Anderson GM. A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: a Monte Carlo method. Stat Med. 2007; 26:734-753.
12. Klein JP, Moeschberger ML. Survival Analysis: Techniques for Censored and Truncated Data. New York, NY: Springer-Verlag; 1977.
13. Kirtane AJ, Gupta A, Iyengar S, Moses JW, Leon MB, Applegate R, Brodie B, Hannan EL, Harjai K, Jensen LO, Park S-J, Perry R, Racz M, Saia F, Tu JV, Waksman R, Lansky AJ, Mehran R, Stone GW. Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-anal-ysis of randomized trials and observational studies. Circulation. 2009; 119:3198-3206.
14. Hannan EL, Racz MJ, McCallister BD, Ryan TJ, Arani DT, Isom OW, Jones RH. A comparison of three-year survival after coronary artery bypass graft surgery and percutaneous transluminal coronary angioplasty. J Am Coll Cardiol. 1999;33:63-72.
15. Baroletti S, Dell'Orfano H. Medication adherence in cardiovascular disease. Circulation. 2010;121:1455-1458.
16. Newby LK, LaPoint NMA, Chen AY, Kramer JM, Hammill BG, DeLong ER, Muhlbaier LH, Califf RM. Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease. Circulation. 2006;113:203-212.
17. Jackevicius CA, Li P, Tu JV. Prevalence, predictors and outcomes of primary non-adherence after acute myocardial infarction. Circulation. 2008;117:1028-1036.
18. Jackevicius CA, Mamdani M, Tu JV. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA. 2002;288:462-467.
19. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353:487-497.
20. Ho PM, Bryson CL, Rumsfeld JS. Medication adherence: its importance in cardiovascular outcomes. Circulation. 2009;119:3028-3035.
21. Borden WE, Redberg RF, Mushlin AI, Dai D, Kaltenbach LA, Spertus JA. Patterns and intensity of medical therapy in patients undergoing percutaneous coronary intervention. JAMA. 2011;305:1882-1889.
22. Rasmussen JN, Chong A, Alter DA. Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after myo-cardial infarction. JAMA. 2007;297:177-186.
23. Ho PM, Magid DJ, Shetterly SM, Olson KL, Maddox KM, Peterson PN, Masoudi FA, Rumsfeld JS. Medication adherence is associated with a broad range of adverse outcomes in patients with coronary artery disease. Am Heart J. 2008;155:772-779.
24. Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care. 2005;43:521-530.
25. Simpson SH, Eurich DT, Majundar SR, Padwal RS, Tsuyuki RT, Vaeney J, Johnson JA. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ. 2006;49:33: 18-26.
26. Spertus JA, Kettelcamp R, Vance C, Decker C, Jones PG, Rumsfeld JS, Messenger JC, Khanal S, Peterson ED, Bach RG, Krumholz HM, Cohen DJ. Prevalence, predictors and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation. 2006;113:2803-2809.